REFRESH #5 IN AMSTERDAM – BIO-EUROPE SPRING STARTUP SOCIAL
14 March 2018, Amsterdam, The Netherlands
It’s time for BIO-Europe Spring, one of the most anticipated events on the biotech calendar. And we are lucky enough to be able to co-host our Refresh event right at the conference! (Does that mean we’re cool?) We’re inviting you to join us and the rest of the BIO-Europe Spring gang for a relaxed biotech meetup on the 14th March 2018.
Because this will be a pretty popular event, we are unfortunately going to have to be a little bit selective. Fill in this super quick form and we will let you know if you are one of the lucky ones! (https://labiotech.typeform.com/to/wtOUej). Don’t forget to still click attending on the Meetup page!
This Refresh is focused on biotech startups, discussing the biggest challenges faced by startups, trends, risks, and ideas for growth & financing. This will involve a panel discussion followed by one fireside chat.
Refresh is still free! We also have a bonus for those who are attending Refresh but not BIO-Europe Spring. You will get a free pass to BIO-Europe Spring for the rest of Wednesday! This means a free entry for the closing ceremony and all other events taking place on Wednesday 14th after Refresh. What a deal.
Get ready to meet some great people, listen to some awesome speakers, and enjoy some free beer. You will be able to find us at the Amsterdam RAI Convention Centre looking super cool in our Labiotech t-shirts.
Thanks to EBD Group for being such a cool partner 😉
Biotech companies are a high-risk, long-term venture, making it particularly challenging to raise funds and scale a successful company. For the startups making a debut in the biotech world, it is important to foresee the challenges they will encounter along the way. This panel will gather biotech companies at various stages of development, from early R&D to commercialization, to discuss the main challenges they are facing and how they are solving them.
Who will be on the panel?
1. Eduardo Bravo – CEO of TiGenix
After beginning his career in big pharma, Eduardo Bravo took the plunge into biotech in 2005 when he saw the opportunity for a breakthrough therapy at a small Spanish biotech called Cellerix. The company became part of TiGenix in 2011, and when they merged, Bravo became CEO.
2. Shelley Margetson – CEO of Gadeta
Before joining with Gadeta, Shelley was the CFO at Merus where she helped to raise over €100M in private financing rounds from blue-chip VCs and big pharma corporate venture investors! She also led the successful IPO of Merus on Nasdaq. A financing genius!
3. Thomas de Vlaan – Founder/ CEO of Smylon Therapeutics
De Vlaam came up with AT-010, a drug candidate for the treatment of Katwijk‘s disease, during his time at ProQR. When it became clear that he had something huge on his hands, he led the charge as CEO to form Amylon. The company, based in Leiden, focuses on CNS disorders using an ultra-genetics approach.
In this one-to-one session, we will talk with a biotech investor about the trends, opportunities, and risks to take into account and how to best tackle them to make your company attractive to investors. We’ll discuss the most effective strategies to pitch your biotech startup, find investors that match your goals and ultimately, raise the funds that will turn your technology into a successful venture. Who will be speaking?
13:30 pm – 14:30 pm: Warm welcoming
14:30 pm – 15:10 pm: Panel Discussion
15:10 pm – 15:30 pm: Fireside Chat
15:30 pm-16:30 pm: Enjoy beers, snacks, and networking
16:30 pm: BIO-Europe Spring closing reception
Hope to see you all there 😉
Katherine & the Labiotech Team
P.S. If you have any questions or suggestions, please feel free me to reach out to me at katherine-at-labiotech.eu
This content is blocked. Accept cookies to view the content.